RecruitingEarly Phase 1NCT06656754

R01.Aim 2.Study 1: IsoReach

Error-enhanced Learning & Recovery in 2 & 3 Dimensions


Sponsor

Shirley Ryan AbilityLab

Enrollment

56 participants

Start Date

Nov 17, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To determine the effects of 3D isometric movement training in healthy participants and impaired participants due to a stroke.


Eligibility

Min Age: 18 Years

Inclusion Criteria9

  • years old
  • No history of stroke
  • Ability to provide informed consent .
  • years old
  • Chronic stroke (8+ months post)
  • Available medical records and radiographic information about lesion locations
  • Hemiparesis
  • Primary motor cortex involvement
  • Some degree of both shoulder and elbow movement capability

Exclusion Criteria30

  • Severe medical problems (including cardiovascular, orthopedic, or neurological)
  • Medical problems affecting movement, range of motion, strength, or coordination of the upper extremities.
  • Visual deficits that would influence the ability to perform the experiment . This will be assessed using the following assessments:
  • Visual field deficits will be assessed using the BIVABA acuity testing. (cutoff score \> 20/100)
  • Depth perception deficits will be assessed using the Stereofly test (require at least an angle of stereopsis at 16 inches is 3,552 seconds of arc).
  • \) Blood pressure above 140 systolic and/or 90 diastolic mmHG
  • \) Blood oxygen reading of less than 92% by finger pulse oximeter testing.
  • Bilateral paresis
  • Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to perform the experiment, This will be assessed using the Mini Mental State Examination31, with cut-off scores (adjusted for education level) as follows:
  • Participants whose education are 7th grade or lower, a score 22 or lower
  • Participants whose education attainment level is 8th grade or some high school (but not a graduate), a score of 24 or lower
  • Participants whose education attainment level is high school graduate, a score of 25 or lower
  • Participants whose education attainment level is some college or higher, a score 26 or lower
  • Visual deficits, and hemispatial neglect that would prevent the participants from seeing the targets. A vision test will be done if the participant indicates in their screen that their stroke has affected their vision. This will be tested using the following assessments:
  • Visual field loss will be assessed using the BIVABA acuity test10. (cutoff score \> 20/100)
  • Visual Extinction and Inattention using Star Cancellation Test9. (cutoff score of \<44)
  • Depth perception deficits will be assessed using the Stereofly test (require at least an angle of stereopsis at 16 inches is 3,552 seconds of arc).
  • Modified Ashworth score of 4 at shoulder or elbow joints.
  • Rated below 15 on the FMUE scale
  • Inability to provide an informed consent
  • severe current medical problems
  • Severe sensory deficit in the affected limb (Cannot be absent in any part of affected UE)
  • diffuse/multiple lesion sites or multiple stroke events
  • Inability to attain and maintain testing positions
  • Botox or other botulinum toxin injection to the affected upper extremity within the previous 4 months
  • Concurrent participation in upper extremity rehabilitation either as part of a research intervention protocol or a prescribed therapy
  • Neurological, neuromuscular, or orthopedic diseases (i.e. injuries to your affected arm or hand)
  • Other neurological issues (Parkinson's, CP)
  • Blood Pressure above 140 systolic and/or 90 diastolic mmHg
  • Blood oxygen reading of less than 92% on finger pulse oximetry testing.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERIsometric Reaching

The intervention of "Isometric Reaching" is the process of restricting the participant's hand movement in place, while using the forces they apply to the robot handle to drive a reaching arm simulation


Locations(1)

Shirley Ryan AbilityLab

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06656754


Related Trials